SCIB1

SCIB1 is a genetically-engineered cancer vaccine being developed by Scancell Holdings Plc as a treatment for melanoma.[1]

External links

References

  1. ↑ "Scancell Licensing Pact With US Health Agency". Wall Street Journal. 2010-05-11. Retrieved 2010-05-17.


This article is issued from Wikipedia - version of the Monday, January 02, 2012. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.